Research Advancing to Market Production for Innovators Act
- Sponsor
- Sen. Coons, Christopher A. [D-DE]
- Committees
- Small Business and Entrepreneurship Committee (primary)
- Last action
- May 7, 2025
Bottom line
This bill aims to accelerate the transition of federally funded small business research and development into marketable products and services by strengthening commercialization support and oversight within the SBIR and STTR programs.
What it actually does
This bill amends the Small Business Act to enhance the commercialization focus of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. It mandates commercialization expertise in peer reviews, expands funding flexibility for agencies, creates a new Technology Commercialization Official role, increases and broadens technical and business assistance (TABA) including cybersecurity, integrates I-Corps participation, establishes an annual commercialization impact assessment, and provides for prioritized patent examination for award recipients.
Proponents argue
Supporters argue that this bill will streamline the path from innovative research to market production, ensuring that taxpayer investments in federal R&D yield tangible economic benefits. They contend that by focusing on commercialization earlier, providing more flexible and targeted support, and improving intellectual property protection, the bill will empower small businesses to scale their innovations, create jobs, and enhance American competitiveness.
Opponents contend
Critics might express concerns that an increased emphasis on commercialization in early-stage reviews could inadvertently shift focus away from high-risk, foundational research that may not have immediate market applications but is crucial for long-term scientific advancement. Some may also argue that the new administrative roles and reporting requirements could add unnecessary bureaucracy or divert resources from core research activities.
The bill is concise and clearly structured, allowing an informed reader to understand its provisions and implications within a short timeframe.
Section 2(a)(1)(D) and (2)(D)
Enhanced Commercialization Focus in Peer Review
This provision requires federal agencies conducting SBIR and STTR programs to include the likelihood of commercialization as a key factor in peer review, alongside scientific and technical merit. It also mandates that at least one reviewer in the peer review process must possess commercialization expertise to assess market potential. Additionally, it shortens certain administrative timeframes from one year to 180 days.
Supporters argue
Supporters argue that integrating commercialization expertise and criteria into early-stage peer review ensures that federal R&D investments are more likely to translate into marketable products and services, fostering economic growth and maximizing the return on public funds.
Critics contend
Critics might contend that an overemphasis on commercialization too early in the research cycle could inadvertently discourage groundbreaking, high-risk basic research that may not have immediate market applications but could lead to future transformative breakthroughs.
Tradeoffs
This provision navigates the tension between funding fundamental scientific exploration and ensuring that research yields practical, market-ready innovations, aiming to strike a balance that promotes both.
Section 3(a)
Expanded Phase Flexibility for Federal Agencies
This section extends and broadens the authority for federal agencies to provide additional awards, often referred to as 'Phase 0' or 'Phase II.5' awards, which bridge the gap between traditional research phases. Previously limited to NIH, DoD, and the Department of Education, this flexibility is now granted to all federal agencies with SBIR or STTR programs for fiscal years 2025-2027. It caps these awards at 10% of total SBIR/STTR funds for most agencies, and 15% for the National Institutes of Health.
Section 4
Designation of Technology Commercialization Official
This section mandates that each federal agency participating in the SBIR or STTR program must designate an existing official as its Technology Commercialization Official. This official is tasked with providing guidance to awardees, advocating for technologies ready for Phase III or other contracts, coordinating with other agencies to identify market pathways, and submitting annual reports on commercialization progress and improvements to the application process.
Section 5
Expanded Technical and Business Assistance (TABA)
This provision significantly enhances the Technical and Business Assistance (TABA) program. It allows SBIR/STTR award recipients to select their own vendors for assistance, including new cybersecurity assistance, or to use TABA funds to hire or augment staff for training. It also increases the maximum TABA funding: up to $6,500 for Phase I projects (from $5,000) and up to $50,000 for Phase II projects, with greater flexibility on whether these funds are included in or added to the base award.
Section 8
Prioritized Patent Examination and Outreach
This section requires the Administrator of the Small Business Administration (SBA) to collaborate with the Director of the United States Patent and Trademark Office (USPTO) to establish a prioritized patent examination program specifically for recipients of SBIR and STTR awards. Additionally, it mandates coordination between the SBA and USPTO to provide outreach regarding the USPTO's Pro Se Assistance Program and its services for scam prevention.
This provision changes the timeframe for certain actions within the SBIR and STTR programs from '1 year' to '180 days'. While the specific actions are not detailed in the bill text, this technical amendment implies a significant acceleration of administrative or reporting deadlines for program participants.
Section 2(a)(1)(A) and (2)(A)
Why it matters:This is standard legislative practice for making technical adjustments to existing statutes, assuming familiarity with the underlying law. It is not necessarily evasive, but its full implications require knowledge of the referenced sections of the Small Business Act.
Case for: Proponents would argue that shortening these timeframes will accelerate program operations, reduce delays, and push projects toward commercialization more quickly, increasing efficiency and responsiveness.
Case against: Critics might suggest that shortening these deadlines could create undue pressure or administrative burden on small businesses, potentially compromising the quality of submissions or compliance if insufficient time is provided for complex tasks.
Estimated impact: This change will accelerate administrative processes for SBIR/STTR awardees and agencies, potentially impacting project timelines and reporting cycles.
This subsection states that 'A Federal agency may perform targeted reviews of technical and business assistance funding as described in subsection (mm)(1)(F).' This refers to an existing authority within the Small Business Act for targeted reviews, indicating that while TABA funding is being expanded and made more flexible, there is an existing mechanism for oversight.
Section 5(4)
Why it matters:This is standard legislative drafting, referencing existing statutory authority rather than restating it. It ensures continuity of oversight mechanisms without adding redundant text.
Case for: Proponents would argue that this explicit reference reinforces accountability for the expanded TABA funds, ensuring that agencies retain the ability to review how these resources are being utilized and whether they are achieving their intended goals.
Case against: No specific opposition is typically raised against maintaining oversight mechanisms, as they are generally considered good governance.
Estimated impact: This provision maintains existing oversight capabilities for TABA funding, ensuring accountability for the expanded program.